Viewing Study NCT04675866


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-27 @ 8:25 AM
Study NCT ID: NCT04675866
Status: UNKNOWN
Last Update Posted: 2022-04-15
First Post: 2020-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module